(Q74453942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

meta-analysis

0 references

title

The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

1 reference

N Mittmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N Herrmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

T R Einarson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

U E Busto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K L Lanctôt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

B A Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

K I Shulman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

I L Silver

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C A Narango

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

N H Shear

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

Journal of Affective Disorders

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

191-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

Trazodone in late life depressive states: a double-blind multicenter study versus amitriptyline and mianserin

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Efficacy of moclobemide in different patient groups: a meta-analysis of studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Use of MAO inhibitors in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A comparative study of conventional and controlled-release formulations of trazodone in elderly depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Suicide in late life. Review and commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Clomipramine therapy in the geriatric hospital: experience with therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A method for assessing the quality of a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Unipolar depression in the elderly. Reoccurrence on discontinuation of tricyclic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

The safety of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Moclobemide compared with second-generation antidepressants in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Fluoxetine Versus Trazodone in Depressed Geriatric Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Clinical predictors of response to antidepressants in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

How effective and safe is continuation therapy in elderly depressed patients? Factors affecting relapse rate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Comparative Side Effect Profiles of Trazodone and Imipramine: Special Reference to the Geriatric Population

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Primary care treatment of depression in the elderly: a double-blind, multi-centre study of flupenthixol ('Fluanxol') and sustained-release amitriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Treating geriatric depression: a 26-week interim analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Nortriptyline response in elderly depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Effects of nortriptyline on the mental and social adjustment of geriatric patients in a mental hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Trazodone. A comparative clinical and predictive study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Use of antidepressants in medically ill older patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Plasma levels and effects of nortriptyline in geriatric depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Clomipramine in the elderly: tolerance and plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Post-stroke depression: combined treatment with imipramine or desipramine and mianserin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Efficacy of phenelzine in geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

"Best-evidence synthesis: an intelligent alternative to meta-analysis": discussion. A case of "either-or" or "as well".

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A quality assessment of randomized control trials of primary treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Nortriptyline treatment of post-stroke depression: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Assessment of quality of life in the treatment of major depressive disorder with fluoxetine, 20 mg, in ambulatory patients aged over 60 years

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Repetitive publication, meta-analysis, and adverse events

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Controlled Trial of Nomifensin (HOE 984) and Viloxazine in the Treatment of Depression in the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

The optimal dosing regimen for citalopram--a meta-analysis of nine placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Differential dosing of trazodone in elderly depressed patients: a study to investigate optimal dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Desipramine treatment of major depression in patients over 75 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Nortriptyline Side Effects During Double-Blind, Randomized, Placebo-Controlled Maintenance Therapy in Older Depressed Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A double-blind comparison of mianserin and maprotiline in depressed medically ill elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Twice may be too many: redundant publications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Best evidence synthesis: an intelligent alternative to meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

The effect of low dose lofepramine in depressed elderly patients in general medical wards

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A double-blind trial: vivalan against placebo in depressed elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

A Controlled Trial of Antidepressant Medication in Elderly In-Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2897%2900107-9

7 January 2021

10.1016/S0165-0327(97)00107-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9547117%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference